NeuroPace (NPCE) News Today → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free NPCE Stock Alerts $13.97 +0.98 (+7.54%) (As of 05:12 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNeuroPace (NPCE) Scheduled to Post Quarterly Earnings on Wednesdayamericanbankingnews.com - May 1 at 4:58 AMOrbimed Advisors Llc Sells 1,781 Shares of NeuroPace, Inc. (NASDAQ:NPCE) Stockamericanbankingnews.com - April 28 at 5:30 AMNeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Orbimed Advisors Llc Sells 1,781 Sharesinsidertrades.com - April 27 at 7:15 AMNeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Orbimed Advisors Llc Sells 24,609 Sharesamericanbankingnews.com - April 24 at 4:56 AMNeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Sells $345,756.45 in Stockinsidertrades.com - April 24 at 4:47 AMInsider Selling: NeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Sells 24,609 Shares of Stockmarketbeat.com - April 23 at 9:13 PMOrbiMed Advisors sells shares in NeuroPace worth over $238,000investing.com - April 20 at 7:32 AMInsider Selling: NeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Sells 2,623 Shares of Stockinsidertrades.com - April 19 at 6:53 AMNeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Sells $36,879.38 in Stockmarketbeat.com - April 18 at 6:51 PMNeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024globenewswire.com - April 17 at 4:05 PMNeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Sells $6,692,916.51 in Stockinsidertrades.com - April 16 at 4:17 AMOrbimed Advisors Llc Sells 461,899 Shares of NeuroPace, Inc. (NASDAQ:NPCE) Stockmarketbeat.com - April 15 at 6:47 PMNeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Rating of "Moderate Buy" from Brokeragesmarketbeat.com - April 14 at 4:07 AMShort Interest in NeuroPace, Inc. (NASDAQ:NPCE) Grows By 178.0%marketbeat.com - April 12 at 12:14 AMNeuroPace (NASDAQ: NPCE)fool.com - April 10 at 3:47 PMKent Lake Capital LLC Buys 96,529 Shares of NeuroPace, Inc. (NASDAQ:NPCE)marketbeat.com - April 6 at 7:28 PM'Biggest mistake' bond investors may make ahead of Fed rate cutsmsn.com - April 4 at 7:38 PMNeuroPace to Present at the Needham 23rd Annual Healthcare Conferenceglobenewswire.com - March 27 at 4:05 PMNeuroPace, Inc. (NASDAQ:NPCE) Given Consensus Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - March 20 at 5:13 AMNeuroPace (NASDAQ:NPCE) Raised to Overweight at Wells Fargo & Companymarketbeat.com - March 14 at 8:37 AMNeuroPace, Inc. (NASDAQ:NPCE) Short Interest Down 19.8% in Februarymarketbeat.com - March 14 at 6:54 AMThe Latest Analyst Ratings For NeuroPacemarkets.businessinsider.com - March 13 at 5:40 AMFmr LLC Trims Stock Holdings in NeuroPace, Inc. (NASDAQ:NPCE)marketbeat.com - March 9 at 4:21 AMQ1 2024 Earnings Estimate for NeuroPace, Inc. (NASDAQ:NPCE) Issued By Leerink Partnrsmarketbeat.com - March 8 at 6:19 AMNeuroPace Secures Buy Rating from Analyst Mike Kratky Amid Positive Revenue Guidance and Growth Driversmarkets.businessinsider.com - March 7 at 1:04 PMNeuroPace, Inc. (NASDAQ:NPCE) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 7 at 1:04 PMNeuroPace Full Year 2023 Earnings: EPS Beats Expectationsfinance.yahoo.com - March 7 at 8:04 AMResearch Analysts Set Expectations for NeuroPace, Inc.'s Q1 2025 Earnings (NASDAQ:NPCE)marketbeat.com - March 7 at 7:38 AMNeuroPace, Inc. (NPCE) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 7 at 3:02 AMRecap: NeuroPace Q4 Earningsbenzinga.com - March 6 at 5:01 PMNeuroPace GAAP EPS of -$0.23msn.com - March 6 at 5:01 PMNeuroPace Financial Analysis: Hold Rating Maintained Amid Growth and Spending Concernsmarkets.businessinsider.com - March 6 at 5:01 PMNeuroPace Announces Record Full Year 2023 Revenue of $65.4 Millionglobenewswire.com - March 5 at 4:05 PMFinancial Freedom Fighters: 3 Stocks to Liberate Your Portfolioinvestorplace.com - March 5 at 2:00 PMNeuroPace (NPCE) Price Target Increased by 27.95% to 15.01msn.com - February 24 at 2:37 AM141,616 Shares in NeuroPace, Inc. (NASDAQ:NPCE) Purchased by EAM Investors LLCmarketbeat.com - February 23 at 8:46 AMA Glimpse Into The Expert Outlook On NeuroPace Through 4 Analystsbenzinga.com - February 22 at 12:53 PMNeuroPace Stock (NASDAQ:NPCE) Earnings Dates and Earning Callsbenzinga.com - February 22 at 7:53 AMNeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024finance.yahoo.com - February 15 at 6:46 PMNeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024globenewswire.com - February 15 at 4:05 PMNeuroPace Announces Chief Legal Officer Irina Ridley’s Departuremsn.com - February 8 at 10:19 AMNeuroPace Inc Chief Medical Officer Martha Morrell Sells 17,589 Sharesuk.finance.yahoo.com - February 7 at 9:59 AMNeuroPace Inc Chief Medical Officer Martha Morrell Sells 13,848 Sharesfinance.yahoo.com - February 2 at 1:18 AMNeuroPace, Inc. (NASDAQ:NPCE) to Post Q1 2024 Earnings of ($0.35) Per Share, Leerink Partnrs Forecastsmarketbeat.com - January 31 at 6:53 AMLeerink Partnrs Reiterates Outperform Rating for NeuroPace (NASDAQ:NPCE)marketbeat.com - January 31 at 6:21 AMNeuroPace, Inc. (NASDAQ:NPCE) Given Average Recommendation of "Moderate Buy" by Analystsmarketbeat.com - January 30 at 8:32 AMSVB Leerink Initiates Coverage on NeuroPace (NASDAQ:NPCE)marketbeat.com - January 30 at 8:23 AMInsider Selling: NeuroPace, Inc. (NASDAQ:NPCE) Insider Sells 827 Shares of Stockmarketbeat.com - January 26 at 7:02 PMNeuroPace, Inc. (NASDAQ:NPCE) Sees Significant Decrease in Short Interestmarketbeat.com - January 14 at 6:36 PMAnalysts Offer Insights on Healthcare Companies: NeuroPace (NPCE), Alignment Healthcare (ALHC) and 10x Genomics (TXG)markets.businessinsider.com - January 9 at 5:37 PM Get NeuroPace News Delivered to You Automatically Sign up to receive the latest news and ratings for NPCE and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him NPCE Media Mentions By Week NPCE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NPCE News Sentiment▼0.910.35▲Average Medical News Sentiment NPCE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NPCE Articles This Week▼41▲NPCE Articles Average Week Get NeuroPace News Delivered to You Automatically Sign up to receive the latest news and ratings for NPCE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Pulse Biosciences News Anika Therapeutics News Surmodics News Tactile Systems Technology News Bioventus News Beauty Health News Fractyl Health News OraSure Technologies News Lyra Therapeutics News CVRx News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NPCE) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget Nvidia. This is the future of AIPorter & CompanyBiden out June 13; Kamala won’t replace him?Paradigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing4 coins to be the “Next Bitcoin”True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroPace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
